Literature DB >> 23033257

Post-market drug safety evidence sources: an analysis of FDA drug safety communications.

Chieko Ishiguro, Marni Hall, George A Neyarapally, Gerald Dal Pan.   

Abstract

Mesh：

Year:  2012        PMID： 23033257     DOI： 10.1002/pds.3317

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  16 in total

1.  An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System.

Authors:  Kathryn Marwitz; S Christopher Jones; Cindy M Kortepeter; Gerald J Dal Pan; Monica A Muñoz
Journal:  Drug Saf       Date:  2020-05       Impact factor: 5.606

2.  A description of signals during the first 18 months of the EMA pharmacovigilance risk assessment committee.

Authors:  Alexandra C Pacurariu; Preciosa M Coloma; Anja van Haren; Georgy Genov; Miriam C J M Sturkenboom; Sabine M J M Straus
Journal:  Drug Saf       Date:  2014-12       Impact factor: 5.606

3.  Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres.

Authors:  Agnes Kant; Loes de Vries; Leàn Rolfes
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

4.  Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility.

Authors:  Monica A Muñoz; Gerald J Dal Pan; Yu-Jung Jenny Wei; Chris Delcher; Hong Xiao; Cindy M Kortepeter; Almut G Winterstein
Journal:  Drug Saf       Date:  2020-04       Impact factor: 5.606

5.  United States Food and Drug Administration Product Label Changes.

Authors:  Leon Kircik; Julie C Sung; Linda Stein-Gold; Gary Goldenberg
Journal:  J Clin Aesthet Dermatol       Date:  2017-02-01

6.  United States Food and Drug Administration Product Label Changes.

Authors:  Leon Kircik; Julie C Sung; Linda Stein-Gold; Gary Goldenberg
Journal:  J Clin Aesthet Dermatol       Date:  2016-01

7.  A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England.

Authors:  Kinan Mokbel; Rob Daniels; Michael N Weedon; Leigh Jackson
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

8.  Predicting the Drug Safety for Traditional Chinese Medicine through a Comparative Analysis of Withdrawn Drugs Using Pharmacological Network.

Authors:  Mengzhu Xue; Shoude Zhang; Chaoqian Cai; Xiaojuan Yu; Lei Shan; Xiaofeng Liu; Weidong Zhang; Honglin Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-29       Impact factor: 2.629

9.  Consumer Narratives in ADR Reporting: An Important Aspect of Public Health? Experiences from Reports to a Swedish Consumer Organization.

Authors:  Andreas Vilhelmsson
Journal:  Front Public Health       Date:  2015-09-01

10.  Consumer Understanding, Preferences, and Responses to Different Versions of Drug Safety Messages in the United States: A Randomized Controlled Trial.

Authors:  Lauren McCormack; R Craig Lefebvre; Carla Bann; Olivia Taylor; Paula Rausch
Journal:  Drug Saf       Date:  2016-02       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.